axial spondyloarthritis

Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Fierce Pharma
Mon, 06/1/20 - 11:32 pm
Eli Lilly
Taltz
Novartis
Cosentyx
axial spondyloarthritis
Novartis stacks more positive PhIII data on Cosentyx franchise — eyeing approval in non-radiographic axial spondyloarthritis
Endpoints
Wed, 10/2/19 - 10:54 am
Novartis
Cosentyx
axial spondyloarthritis
Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study
TheStreet.com
Mon, 04/22/19 - 10:17 am
Eli Lilly
axial spondyloarthritis
clinical trials
Taltz